Allergan Gets Patent Claims In Botox Suit Nixed At PTAB
The Patent Trial and Appeal Board on Tuesday invalidated several claims in a pain treatment patent challenged by Allergan Inc., which was hit with infringement allegations in 2015 related to off-label...To view the full article, register now.
Already a subscriber? Click here to view full article